Results 31 to 40 of about 7,760 (164)

Patient Readiness to Adhere to HAART [PDF]

Journal of the International Association of Physicians in AIDS Care, 2009
Objectives: to determine 1) whether patients’ statements of readiness to take HAART predicted adherence and 2) whether previous experience with HAART enabled patients to better predict adherence. Method: Thirty-nine patients (24 naïve to HAART and 15 reinitiating HAART after a hiatus of >6 months) indicated readiness to take HAART on a Likert scale
Deanna E. Grimes, Richard M. Grimes
openaire   +3 more sources

Ocular syphilis in patients with human immunodeficiency virus/acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy

Indian Journal of Ophthalmology, 2020
Purpose: Re-emergent ocular syphilis in patients with Human immunodeficiency virus (HIV) co-infection has both diagnostic and management difficulties because of the overlapping risk factors. The clinical manifestations described in non-HIV may not be the
Sridharan Sudharshan, Nitin K Menia, Poongulali Selvamuthu, Mudit Tyagi, N Kumarasamy, Jyotirmay Biswas   +5 more
doaj   +1 more source

Comparative Review of High‐ and Low‐Temperature Electrochemical Ammonia Synthesis

Electrochemical Science Advances, EarlyView.
This review discusses the current advancements and challenges in low‐temperature and high‐temperature electrochemical nitrogen reduction reaction (eNRR) methodologies. It highlights the potential of lithium‐mediated systems in molten salts and organic solvents for industrial application, emphasizing the need for rigorous testing, standardized research ...
Yannik Kohlhaas, Lucy Nohl, Robert Keller, Lambertus GJ de Haart, Ruediger‐Albert Eichel, Matthias Wessling   +5 more
wiley   +1 more source

HIV, HAART and overseas visitors [PDF]

Sexually Transmitted Infections, 2006
In March 2004, parliament passed amendments to the overseas visitors legislation, which came into effect from April 2004. According to the Department of Health guidelines, overseas visitors are eligible for free National Health Service (NHS) secondary medical services in certain circumstances.1 Free NHS treatment may be afforded to overseas visitors if
L Collins, V Micunovic, A de Ruiter, A Fowler, Nick Larbalestier, Ranjababu Kulasegaram   +5 more
openaire   +3 more sources

Exploring the Impact of Guselkumab and Risankizumab on Psoriasis in HIV‐Positive Patients: Insights From Four Italian Centers

Australasian Journal of Dermatology, EarlyView.
ABSTRACT HIV‐positive patients with psoriasis often face delays in accessing biologic therapies due to their exclusion from clinical trials and concerns about the impact of immunomodulatory drugs on viral replication. Anti‐IL‐23 therapies, such as risankizumab and guselkumab, have shown great promise thanks to their strong efficacy and favourable ...
V. Maione, S. Rovaris, C. Romanó, S. Bighetti, M. Arisi, C. G. Carrera, F. Bellinato, P. Gisondi, Z. Fratton, E. Errichetti, L. Bettolini   +10 more
wiley   +1 more source

Pneumocystis jirovecii pneumonia–Immune reconstitution inflammatory syndrome: A review of published cases

HIV Medicine, EarlyView.
Abstract Background Immune reconstitution inflammatory syndrome (IRIS) can occur in patients with HIV after commencing antiretroviral therapy. Tuberculosis–IRIS is the most common, and Pneumocystis jirovecii pneumonia (PJP)–IRIS accounts for only 2.7%–4% of IRIS cases.
Natasha Marcella Vaselli, Kris Salaveria, James Winearls, Katherine Garnham   +3 more
wiley   +1 more source

A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context

Farmeconomia: Health Economics and Therapeutic Pathways, 2017
BACKGROUND: Highly Active Antiretroviral Therapy (HAART) has transformed HIV into a lifelong condition. Following the chronicity of the disease, and significant increase in lifespan – the prevalence of comorbidities increased in HIV+ subjects that are ...
Lorenzo Pradelli, Giovanni Di Perri, Giuliano Rizzardini, Elisa Martelli, Stefano Giardina, Massimiliano Povero   +5 more
doaj   +1 more source

Rethinking HIV treatment: How non‐integrase strand regimens may hold the key to better immune health

HIV Medicine, EarlyView.
Abstract Purpose HIV outcome changed drastically with antiretroviral (ARV) therapy, especially after the introduction of second‐generation integrase strand transfer inhibitors (INSTIs). Despite these advances, however, chronic immune activation and exhaustion, marked by programmed cell death 1 (PD‐1) and programmed death ligand 1 (PD‐L1) upregulation ...
Bogusz Aksak‐Wąs, Karolina Skonieczna‐Żydecka, Miłosz Parczewski, Rafał Hrynkiewicz, Filip Lewandowski, Karol Serwin, Kaja Mielczak, Franciszek Lenkiewicz, Paulina Niedźwiedzka‐Rystwej   +8 more
wiley   +1 more source

Global Perspective of Novel Therapeutic Strategies for the Management of NeuroAIDS

Biomolecular Concepts, 2018
Among Human immunodeficiency virus (HIV) infected individuals, around two-thirds of patients present with neuroAIDS, where HIV-associated neurocognitive disorders (HAND), and HIV-associated dementia (HAD) are the most prevailing neurological ...
Kumar Swatantra, Maurya Vimal K, Dandu Himanshu R, Bhatt Madan LB, Saxena Shailendra K   +4 more
doaj   +1 more source

Study of association of urine albumin to creatinine ratio with endothelial dysfunction in HIV patients on HAART

Asian Journal of Medical Sciences, 2021
Background: In HIV (Human immunodeficiency virus) positive patients several factors have been proposed to explain the cardiovascular (CV) risk, which include pro-athero-thrombotic viral effect, infection-mediated immune dysfunction and possible effects ...
Sharana Basava Hoskera , Avinash Hanbe Rajanna , Nitish Ashok Gurav , Ashok ML   +3 more
doaj   +1 more source